Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

CHLORPHENIRAMINE POLISTIREX

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 6 USDMF, 1 CEP/COS, 3 EU WC, 3 KDMF, 3 NDC API, 8 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers, 14 FDA Orange Book, 2 Europe, 3 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML, SYRUP;ORAL - 2MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 3 SPI Pharma, 4 DKSH, 2 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 7 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 6 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 BASF, 1 Bioplus Life Sciences, 4 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 19 Kerry, 10 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 18 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 19 Thickeners and Stabilizers, 19 Direct Compression, 15 Disintegrants & Superdisintegrants, 14 Film Formers & Plasticizers, 13 Granulation, 12 Taste Masking, 11 Lubricants & Glidants, 11 Co-Processed Excipients, 10 Coating Systems & Additives, 9 Parenteral, 7 Chewable & Orodispersible Aids, 7 Topical, 6 Controlled & Modified Release, 6 Solubilizers, 4 Emulsifying Agents, 3 API Stability Enhancers, 3 Rheology Modifiers, 1 Soft Gelatin

DIGITAL CONTENT

4 News #PharmaBuzz

4 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 Regulatory FDF Prices

2 Regulatory FDF Prices

MARKET PLACE

7 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/03/2025	Supriya Lifescience	India	아이엠씨디코리아주식회사	20210302-211-J-852(2)	Dexchlorpheniramine maleate	2024-09-11	Supriya Lifescience Ltd.	India	A-5/2, Lote Parshuram Industrial Area, MIDC Tal-Khed. Dist-Ratnagiri, Maharashtra, Pin-415 722, India
28/03/2025	Supriya Lifescience	India	Samoh Pharmaceutical Co., Ltd.	20210302-211-J-852	Dexchlorpheniramine maleate	2021-03-02	Supriya Lifescience Ltd	India	A-5/2, Lote Parshuram Industrial Area, MIDC Tal-Khed. Dist-Ratnagiri, Maharashtra, Pin-415 722, India

CHLORPHENIRAMINE POLISTIREX

CHLORPHENIRAMINE POLISTIREX

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers

6 USDMF

1 CEP/COS

3 EU WC

3 KDMF

3 NDC API

8 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers

14 FDA Orange Book

2 Europe

3 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML

SYRUP;ORAL - 2MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

3 SPI Pharma

4 DKSH

2 Pharm-RX Chemical

3 Faran Shimi Pharmaceutical

7 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

6 Actylis

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 BASF

1 Bioplus Life Sciences

4 DFE Pharma

1 Finar

7 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

19 Kerry

10 Microlex e.U

1 Novo Excipients

2 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

18 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

2 Ulanqab Kema New Material

1 Valens Pharmachem

2 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders

19 Thickeners and Stabilizers

19 Direct Compression

15 Disintegrants & Superdisintegrants

14 Film Formers & Plasticizers

13 Granulation

12 Taste Masking

11 Lubricants & Glidants

11 Co-Processed Excipients

10 Coating Systems & Additives

9 Parenteral

7 Chewable & Orodispersible Aids

7 Topical

6 Controlled & Modified Release

6 Solubilizers

4 Emulsifying Agents

3 API Stability Enhancers

3 Rheology Modifiers

1 Soft Gelatin

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons